Market Dynamics:
The key drivers of growth in the oncology radiopharmaceuticals market include increasing incidence of cancer and rising adoption of nuclear medicine in diagnosis and treatment. According to WHO estimates, cancer burden is expected to reach 27.5 million new cases and 16.3 million cancer deaths by 2040 due to aging and growth of the global population. Early detection of...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian